Towa Bank told markets on July 14, 2026 that its board had approved the sale of part of its investment securities portfolio, expecting to raise about ¥11.3bn and book a gain of roughly ¥5.5bn on the transaction. The timing is not routine portfolio management. It is a direct response to a credit problem the bank disclosed a week earlier: a ¥8.0bn claim against a company called Zentoshin, of which ¥5.8bn has no collateral or reserve behind it.
The plan is straightforward accounting arithmetic. Towa Bank intends to use the ¥5.5bn securities gain to absorb the loss-processing charge tied to the uncovered ¥5.8bn Zentoshin exposure. The gain does not fully cover the loss on paper, but the bank says the combination is close enough that its full-year earnings forecast for the year to March 2027, published on May 12, 2026, is expected to stand unchanged.
That forecast is not locked in. The bank's first-quarter results are still being finalized, and Towa Bank says it will revisit the full-year outlook when it reports those results on August 4, 2026. The ¥5.5bn gain figure itself is also provisional: the filing notes it is calculated from current market prices of the securities involved and will move if those prices shift before the sales are completed.
The sales will run over an unusually long window, from July 2026 through March 2027, rather than all at once. That gives the bank flexibility on execution and price, but it also means the eventual gain will not be locked in until the last security is sold, nine months from now.
| Item | Amount |
|---|---|
| Total claim against Zentoshin | ¥8.0bn |
| Uncollateralized portion of the claim | ¥5.8bn |
| Planned securities sale amount | ¥11.3bn |
| Expected gain on sale | ¥5.5bn |
| Planned sale period | July 2026 to March 2027 |
What the disclosure does not say is how Towa Bank's reserve policy or lending limits to a single borrower like Zentoshin will change going forward. The bank frames this as a one-off balance-sheet fix for a single exposure, not a broader shift in credit strategy, and nothing in the filing suggests otherwise.
